Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future


Eshe Nelson
9/1/2026

Novo Nordisk’s chief executive, Mike Doustdar, is a year into a corporate turnaround. He says investors are still underestimating the promise of the company’s drugs....

Original

Tags: a | chief | future | investors | is | mike | ozempic | the | year



Let us know what you think!

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Leave a Comment

Scroll back to top